Fred Hutchinson

This is your central portal for breaking news, the latest research and important updates from Fred Hutchinson. Bookmark this page and check back often for updates.

In the Journals

Allogeneic HSCT survival outcomes show ‘striking improvement’

January 20, 2020
Patients who received allogeneic hematopoietic stem cell transplants between 2013 and 2017 demonstrated substantial improvement in survival outcomes…

Fred Hutchinson Cancer Research Center names new president, director

January 7, 2020
Fred Hutchinson Cancer Research Center has named Thomas J. Lynch Jr., MD, as its president and director. Lynch — recognized for his expertise…

ASH presents Scholar Awards to fellows, junior faculty

December 22, 2019
ASH announced the recipients of its 2019 Scholar Awards. The awards — presented to hematologists in the United States and Canada who conduct…
Meeting News

Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high

December 20, 2019
ORLANDO — The price of generic imatinib has decreased substantially in the United States over the past 2 years, according to a speaker at ASH…
Cover Story

Harnessing the gut to improve cancer outcomes

HemOnc Today, December 10, 2019
The gut microbiome — made up of more than a trillion microbes, archaea, viruses, phages, yeast, fungi and bacteria in the intestine — has…
In the Journals

Melanoma rates decline among US adolescents, young adults

November 13, 2019
Incidence of invasive melanoma decreased among adolescents and young adults in the United States between 2006 and 2015, according to results of a…
Meeting News

Off-the-shelf natural killer cells safe, clinically active for advanced Merkel cell carcinoma

November 8, 2019
NATIONAL HARBOR, Md. — Allogeneic activated natural killer cell therapy resulted in some antitumor activity with no serious side effects in…

Hematologists, oncologists elected to National Academy of Medicine

October 30, 2019
The National Academy of Medicine announced the election of 90 regular members and 10 international members. Election to the academy —…
Feature

NCI-sponsored clinical trials cost-effective, ‘practice influential’

October 22, 2019
A study by the NCI-sponsored SWOG Cancer Research Network showed nearly half of the network’s phase 3 clinical trials influenced clinical care…
Clinical Trials Snapshot

T-cell Responses to Concurrent HIV and Herpesvirus Infections

Cell Therapy Next, October/November 2019
An observational, prospective cohort study to discover new information about how HIV and herpes viruses interact with the immune system, with a goal…
Clinical Trials Snapshot

TCR-engineered T Cells in Solid Tumors (ACTengine)

Cell Therapy Next, October/November 2019
Phase 1 study evaluating the safety and tolerability of genetically modified autologous T cells expressing a T-cell receptor recognizing a…
Clinical Trials Snapshot

NY-ESO-1 TCR Engineered T Cell and HSC After Melphalan Conditioning Regimen in Treating Participants with Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Cell Therapy Next, October/November 2019
Phase 1, open-label study evaluating the safety and efficacy of adoptive transfer of autologous NY-ESO-1 CD8-TCR engineered T cells and NY-ESO-1…
Feature

Hope vs Hype: Managing Patient Expectations for CAR T-Cell Therapy

Cell Therapy Next, October/November 2019
Imagine a young adult male in his late 20s picks up his cell phone and calls his mother. Overtly emotional and on the verge of releasing a full-out…
Clinical Trials Snapshot

HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

Cell Therapy Next, October/November 2019
Phase 1 study to determine the safety and feasibility of using HERV-E TCR-transduced autologous T Cells in patients with metastatic clear-cell…
Clinical Trials Snapshot

HA-1 T TCR T Cell Immunotherapy for the Treating of Patients with Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Cell Therapy Next, October/November 2019
Phase 1 study of adoptive immunotherapy with CD8+ and CD4+ memory T cells transduced to express an HA-1-specific T cell receptor for children and…
Trend Watch

Cameron Turtle Receives Fred Hutch’s Endowed Chair for Immunotherapy

Cell Therapy Next, October/November 2019
Cameron Turtle, MD, PhD, a pioneer in the field of chimeric antigen receptor T-cell therapy, has been honored as the inaugural recipient of the…
Clinical Trials Snapshot

Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Cell Therapy Next, October/November 2019
Phase 1 dose-escalation clinical trial to determine the phase 2 dose of autologous TIL 1383I TCR gene-modified T cells using a retrovirus for…

The Leukemia & Lymphoma Society awards $13.8 million for research into pediatric blood cancers

October 9, 2019
The Leukemia & Lymphoma Society awarded $13.8 million in new pediatric research grants designed to identify more effective and precise treatments…

ASH presents bridge grants to 19 investigators

October 7, 2019
ASH awarded $150,000 each to 19 investigators through the society’s bridge grant program, designed to sustain promising hematologic research…
Feature

Seattle Cancer Care Alliance opens its doors to share its cellular therapy experience

September 18, 2019
The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular…